chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever 100.1; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.1) and HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030214) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (Fever 100.1) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever 100.1) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, SARS-CoV-2 test: positive (Positive) Positive. On 18-Mar-2021, Body temperature: 100.1 (Inconclusive) Inconclusive.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dry throat, Fatigue, Myalgia
Clinical narrative: dry throat; soreness in middle of back; tired; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DRY THROAT (dry throat), BACK PAIN (soreness in middle of back), FATIGUE (tired) and MYALGIA (muscle pain) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter .  Concomitant products included MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced DRY THROAT (dry throat), BACK PAIN (soreness in middle of back), FATIGUE (tired) and MYALGIA (muscle pain). At the time of the report, DRY THROAT (dry throat), BACK PAIN (soreness in middle of back), FATIGUE (tired) and MYALGIA (muscle pain) outcome was unknown.            Patient did not take any medication to treat symptoms
Sex: M
Vaccine: COVID19
Symptoms: Cough, Malaise
Clinical narrative: Not feeling well; Cough; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well) and COUGH (Cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (Not feeling well) and COUGH (Cough). At the time of the report, MALAISE (Not feeling well) and COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Uncontrollable Shaking) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced TREMOR (Uncontrollable Shaking) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 pill. At the time of the report, TREMOR (Uncontrollable Shaking) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 100.9 (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided by the reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza like illness
Clinical narrative: Patient had flu-like symptoms the day after receiving 2nd dose; At night, Patient had severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Patient had flu-like symptoms the day after receiving 2nd dose) and DIARRHOEA (At night, Patient had severe diarrhea) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), ATORVASTATIN CALCIUM (LIPITOR), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), SPIRONOLACTONE, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN D [VITAMIN D NOS], FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and AZELASTINE HYDROCHLORIDE (ASTELIN [AZELASTINE HYDROCHLORIDE]) for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Patient had flu-like symptoms the day after receiving 2nd dose) and DIARRHOEA (At night, Patient had severe diarrhea). At the time of the report, INFLUENZA LIKE ILLNESS (Patient had flu-like symptoms the day after receiving 2nd dose) and DIARRHOEA (At night, Patient had severe diarrhea) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test, Vaccination site mass, Vaccination site pain
Clinical narrative: swollen lymph nodes around her left side of breast; her arm hurt so bad/worst pain; hard lump under left armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes around her left side of breast), VACCINATION SITE PAIN (her arm hurt so bad/worst pain) and VACCINATION SITE MASS (hard lump under left armpit) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (amoxicillin).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes around her left side of breast), VACCINATION SITE PAIN (her arm hurt so bad/worst pain) and VACCINATION SITE MASS (hard lump under left armpit). The patient was treated with IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes around her left side of breast), VACCINATION SITE PAIN (her arm hurt so bad/worst pain) and VACCINATION SITE MASS (hard lump under left armpit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative-3 different times.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash pruritic, Vaccination site rash, Vaccination site warmth
Clinical narrative: Hot to touch; itchy rash; Itchy rash/small rash spread and cover almost all the upper arm; A little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little sore arm), VACCINATION SITE WARMTH (Hot to touch), RASH PRURITIC (itchy rash) and VACCINATION SITE RASH (Itchy rash/small rash spread and cover almost all the upper arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Allergic to sulfa basic medication.). Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN), VITAMIN B COMPLEX and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (A little sore arm). On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch), RASH PRURITIC (itchy rash) and VACCINATION SITE RASH (Itchy rash/small rash spread and cover almost all the upper arm). At the time of the report, PAIN IN EXTREMITY (A little sore arm) had resolved and VACCINATION SITE WARMTH (Hot to touch), RASH PRURITIC (itchy rash) and VACCINATION SITE RASH (Itchy rash/small rash spread and cover almost all the upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .The patient HCP told her to take OTC Benadryl for allergic or if painful take OTC ibuprofen or Tylenol. and put cold compress on it to make it feel better.    Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Added Patient demographic details .( Race information is added.)
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise
Clinical narrative: not been feeling very well - lasted a couple of days; headaches-sporadically today worse than other days; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not been feeling very well - lasted a couple of days) and HEADACHE (headaches-sporadically today worse than other days) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced MALAISE (not been feeling very well - lasted a couple of days) and HEADACHE (headaches-sporadically today worse than other days). At the time of the report, MALAISE (not been feeling very well - lasted a couple of days) and HEADACHE (headaches-sporadically today worse than other days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment with Tylenol was provided by the patient.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Heart rate, Rash
Clinical narrative: Asthma Attack; Rash on her arm and back; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma Attack) and RASH (Rash on her arm and back) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SAZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHMA (Asthma Attack) and RASH (Rash on her arm and back). At the time of the report, ASTHMA (Asthma Attack) and RASH (Rash on her arm and back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: abnormal (abnormal) Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow-up information received on 03-AUG-2021 and contains non-significant information.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: Arm became itchy; Swollen quit far down her arm; Large red dot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm became itchy), PERIPHERAL SWELLING (Swollen quit far down her arm) and ERYTHEMA (Large red dot) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PRURITUS (Arm became itchy), PERIPHERAL SWELLING (Swollen quit far down her arm) and ERYTHEMA (Large red dot). At the time of the report, PRURITUS (Arm became itchy), PERIPHERAL SWELLING (Swollen quit far down her arm) and ERYTHEMA (Large red dot) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Myalgia
Clinical narrative: lower back pain; sore; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain) and MYALGIA (sore) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A17A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced BACK PAIN (lower back pain) and MYALGIA (sore). At the time of the report, BACK PAIN (lower back pain) outcome was unknown and MYALGIA (sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchiness on arm; rash on arm of the injection and it is spreading down to their elbow; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE PRURITUS (itchiness on arm) and VACCINATION SITE RASH (rash on arm of the injection and it is spreading down to their elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Injection site rash on 09-Mar-2021.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness on arm) and VACCINATION SITE RASH (rash on arm of the injection and it is spreading down to their elbow). At the time of the report, VACCINATION SITE PRURITUS (itchiness on arm) and VACCINATION SITE RASH (rash on arm of the injection and it is spreading down to their elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Flatulence
Clinical narrative: Gas; Diarrhea; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FLATULENCE (Gas), DIARRHOEA (Diarrhea) and FATIGUE (Tiredness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced FLATULENCE (Gas), DIARRHOEA (Diarrhea) and FATIGUE (Tiredness). At the time of the report, FLATULENCE (Gas), DIARRHOEA (Diarrhea) and FATIGUE (Tiredness) outcome was unknown.            Concomitant product included thyroid medications.  It was reported that patient could not keep down thyroid medication, and had to be on a liquid diet.   No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and MYALGIA (body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced RHINORRHOEA (runny nose) and MYALGIA (body aches). At the time of the report, RHINORRHOEA (runny nose) and MYALGIA (body aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was not reported. No treatment medication was not reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Fatigue after1st dose; Arm pain after1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm pain after1st dose) and FATIGUE (Fatigue after1st dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L208a) for COVID-19 vaccination.     Concurrent medical conditions included Hepatitis C antibody positive.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm pain after1st dose). On 29-Dec-2020, the patient experienced FATIGUE (Fatigue after1st dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 30-Dec-2020, FATIGUE (Fatigue after1st dose) had resolved. On 01-Jan-2021, PAIN IN EXTREMITY (Arm pain after1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  Patient has reported race information as Black.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Patient denied having any reaction to vaccine. Contact information was updated. Patient's race, height, weight was updated.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Rash
Clinical narrative: cold; Rash on back; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), RASH (Rash on back) and PYREXIA (Fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), RASH (Rash on back) and PYREXIA (Fever). At the time of the report, NASOPHARYNGITIS (cold), RASH (Rash on back) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided by the reporter. No treatment information was provided   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: large red swelling at the injection site; large red swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (large red swelling at the injection site) and VACCINATION SITE ERYTHEMA (large red swelling at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE SWELLING (large red swelling at the injection site) and VACCINATION SITE ERYTHEMA (large red swelling at the injection site). At the time of the report, VACCINATION SITE SWELLING (large red swelling at the injection site) and VACCINATION SITE ERYTHEMA (large red swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Diarrhea; Lack of appetite; Nausea; Fatigue / Tired; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DECREASED APPETITE (Lack of appetite), NAUSEA (Nausea), FATIGUE (Fatigue / Tired) and VOMITING (Vomiting) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included APIXABAN (ELIQUIS) and VITAMIN D NOS for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DECREASED APPETITE (Lack of appetite), NAUSEA (Nausea), FATIGUE (Fatigue / Tired) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea), DECREASED APPETITE (Lack of appetite), NAUSEA (Nausea), FATIGUE (Fatigue / Tired) and VOMITING (Vomiting) outcome was unknown.            No concomitant medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included VITAMINS NOS, CINNAMON [CINNAMOMUM VERUM], MAGNESIUM and TIMOLOL for an unknown indication.    On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). At the time of the report, PAIN IN EXTREMITY (arm was sore) outcome was unknown.            Concomitant medication was not reported. The patient did not use any treatment medication.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: invalid dose administered to two patients; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients). At the time of the report, INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients). At the time of the report, INCORRECT DOSE ADMINISTERED (invalid dose administered to two patients) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-052032 (E2B Linked Report).   This case was linked to US-MODERNATX, INC.-MOD-2021-052032 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-052032:Crosslinked case
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: many reactions after the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (many reactions after the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (many reactions after the first dose). At the time of the report, VACCINATION COMPLICATION (many reactions after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant was not provided Treatment was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-051162, MOD-2021-119592 (E2B Linked Report).; Sender's Comments:  MOD-2021-051162:Same reporter/different patient (1st dose case) MOD-2021-119592:Same reporter/different patient (2nd dose case)
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Fatigue, Headache
Clinical narrative: HEADACHE; FATIGUE; fever 101.9; chills; nose dripping; cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills) and RHINORRHOEA (nose dripping) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills), RHINORRHOEA (nose dripping) and COUGH (cough). At the time of the report, HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills), RHINORRHOEA (nose dripping) and COUGH (cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.9 (High) 101.9 fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment details pertaining to the events were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-051654 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051654:patient case
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: HEADACHE; FATIGUE; fever 101.9; chills; nose dripping; cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills) and RHINORRHOEA (nose dripping) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills), RHINORRHOEA (nose dripping) and COUGH (cough). At the time of the report, HEADACHE (HEADACHE), FATIGUE (FATIGUE), PYREXIA (fever 101.9), CHILLS (chills), RHINORRHOEA (nose dripping) and COUGH (cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.9 (High) 101.9 fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment details pertaining to the events were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-051654 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051654:patient case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Feeling hot, Headache, Influenza like illness
Clinical narrative: flu-like symptoms; itching; 100.1 F. fever; arm lump; arm soreness; arm warm; headache; body aches; very tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump) and PAIN IN EXTREMITY (arm soreness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump), PAIN IN EXTREMITY (arm soreness), FEELING HOT (arm warm), HEADACHE (headache), MYALGIA (body aches) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 18-Mar-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump), PAIN IN EXTREMITY (arm soreness), HEADACHE (headache), MYALGIA (body aches) and FATIGUE (very tired) had resolved. At the time of the report, FEELING HOT (arm warm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Body temperature: 100.1 Farad (High) 100.1 farad.         Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant and treatment information were not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Myalgia, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: flu-like symptoms; itching; 100.1 F. fever; arm lump; arm soreness; arm warm; headache; body aches; very tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump) and PAIN IN EXTREMITY (arm soreness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump), PAIN IN EXTREMITY (arm soreness), FEELING HOT (arm warm), HEADACHE (headache), MYALGIA (body aches) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 18-Mar-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), PRURITUS (itching), PYREXIA (100.1 F. fever), MASS (arm lump), PAIN IN EXTREMITY (arm soreness), HEADACHE (headache), MYALGIA (body aches) and FATIGUE (very tired) had resolved. At the time of the report, FEELING HOT (arm warm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Body temperature: 100.1 Farad (High) 100.1 farad.         Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant and treatment information were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: injection site was warm; the injection was itchy; injection site grew more tender over the course of a few days; red blotch at injection the injection site developed eight days after the vaccine; injection site achy and tender to the touch approximately seven days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy), VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine), VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine). On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine). On an unknown date, the patient experienced INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days). The patient was treated with CORTISONE for Itch, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) for Itch, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy), VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine), VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: It has been 66 days since 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been 66 days since 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: tingling and pin pricks in the back of her tongue; funny sensation; not sure if it (tongue) was getting think or numb; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling and pin pricks in the back of her tongue), FEELING ABNORMAL (funny sensation) and HYPOAESTHESIA ORAL (not sure if it (tongue) was getting think or numb) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PARAESTHESIA ORAL (tingling and pin pricks in the back of her tongue), FEELING ABNORMAL (funny sensation) and HYPOAESTHESIA ORAL (not sure if it (tongue) was getting think or numb). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 18-Mar-2021, PARAESTHESIA ORAL (tingling and pin pricks in the back of her tongue), FEELING ABNORMAL (funny sensation) and HYPOAESTHESIA ORAL (not sure if it (tongue) was getting think or numb) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Aphasia, Atrial tachycardia, Fatigue, Feeling abnormal
Clinical narrative: Anomia; Elevated heart rate/felt like it got to over 100; Tachycardia; Paroxysmal atrial tachycardia (PAT); Uncomfortable feeling on the nervous system, like it's overactivated; Adrenaline feeling/hormonal or neuorchemical feeling; Brain fog; Tingling in the mouth; Feel so tired, and is having a hard time sleeping; Feel so tired, and is having a hard time sleeping; Arm sore; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)) and NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)), NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated), FEELING ABNORMAL (Adrenaline feeling/hormonal or neuorchemical feeling), FEELING ABNORMAL (Brain fog), PARAESTHESIA ORAL (Tingling in the mouth), INSOMNIA (Feel so tired, and is having a hard time sleeping), FATIGUE (Feel so tired, and is having a hard time sleeping) and VACCINATION SITE PAIN (Arm sore). At the time of the report, APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)), NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated), FEELING ABNORMAL (Adrenaline feeling/hormonal or neuorchemical feeling), FEELING ABNORMAL (Brain fog), PARAESTHESIA ORAL (Tingling in the mouth), INSOMNIA (Feel so tired, and is having a hard time sleeping), FATIGUE (Feel so tired, and is having a hard time sleeping) and VACCINATION SITE PAIN (Arm sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Heart rate: 125 (High) heart rate was 125 bpm. On 27-Feb-2021, Antinuclear antibody: positive (High) Positive ANA so high, highest possible..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes Cold showers, Compression stocking, Fluid intake.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Insomnia, Nervous system disorder, Paraesthesia oral
Clinical narrative: Anomia; Elevated heart rate/felt like it got to over 100; Tachycardia; Paroxysmal atrial tachycardia (PAT); Uncomfortable feeling on the nervous system, like it's overactivated; Adrenaline feeling/hormonal or neuorchemical feeling; Brain fog; Tingling in the mouth; Feel so tired, and is having a hard time sleeping; Feel so tired, and is having a hard time sleeping; Arm sore; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)) and NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)), NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated), FEELING ABNORMAL (Adrenaline feeling/hormonal or neuorchemical feeling), FEELING ABNORMAL (Brain fog), PARAESTHESIA ORAL (Tingling in the mouth), INSOMNIA (Feel so tired, and is having a hard time sleeping), FATIGUE (Feel so tired, and is having a hard time sleeping) and VACCINATION SITE PAIN (Arm sore). At the time of the report, APHASIA (Anomia), HEART RATE INCREASED (Elevated heart rate/felt like it got to over 100), TACHYCARDIA (Tachycardia), ATRIAL TACHYCARDIA (Paroxysmal atrial tachycardia (PAT)), NERVOUS SYSTEM DISORDER (Uncomfortable feeling on the nervous system, like it's overactivated), FEELING ABNORMAL (Adrenaline feeling/hormonal or neuorchemical feeling), FEELING ABNORMAL (Brain fog), PARAESTHESIA ORAL (Tingling in the mouth), INSOMNIA (Feel so tired, and is having a hard time sleeping), FATIGUE (Feel so tired, and is having a hard time sleeping) and VACCINATION SITE PAIN (Arm sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Heart rate: 125 (High) heart rate was 125 bpm. On 27-Feb-2021, Antinuclear antibody: positive (High) Positive ANA so high, highest possible..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes Cold showers, Compression stocking, Fluid intake.